| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $22.1M | +18.9% |
| SG&A Expense | $18.3M | -10.8% |
| Operating Income | -$41.0M | -3.3% |
| Income Tax | $0 | — |
| Net Income | -$38.5M | +8.7% |
| EPS (Basic) | -$10.15 | +41.5% |
| EPS (Diluted) | -$10.15 | +41.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.2M | +0.6% |
| Current Assets | $52.8M | -0.1% |
| Total Assets | $55.5M | -0.8% |
| Current Liabilities | $17.0M | +103.2% |
| Long-term Debt | $20.1M | -40.8% |
| Total Liabilities | $43.2M | -10.9% |
| Stockholders' Equity | $12.3M | +64.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.4M | -5.2% |
| Investing Cash Flow | -$208K | +51.5% |
| Financing Cash Flow | $29.9M | +251.2% |